NASDAQ : TDAC
Translational Development Acquisition Corp. — Company profile
Financials · Shell Companies · United States
Last price 10.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 221.67M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Details
| Name | Translational Development Acquisition Corp. |
| Sector | Financials |
| Industry | Shell Companies |
| Founded | 2022 |
| Ipo Date | 2024-12-23 |
| Ceo | Michael M. Hoffman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 10.00 |
| Isin | KYG9008W1050 |
| Cusip | G9008W105 |
| Cik | 1926599 |
| Sic | 6770 |
Key executives
| Name | Title |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board and Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Contact
| Address | 52 E. 83rd Street, New York, New York 10028, United States |
| Phone | 917 979 3072 |
| Website | https://www.translational-development.com |